Flagship explainer
What drives Dare Bioscience, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$13.4M | FY2025 |
| |
| Income before tax | −$13.5M | FY2025 |
|
| Operating income | −$13.6M | FY2025 |
|
| $1M | FY2025 |
| |
| Ending assets | $32.5M | FY2025 |
|
| Beginning assets | $22.1M | FY2024 |
|
| $2.8M | FY2025 |
| |
| −$6M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001401914-26-000004